Assignee
SYLENTIS SAU
ES·12 granted patents·1 pending application·68 citations·filing 2005–2018
Top patents by PatentIndex Score
13 records- 0195US7592325B2Methods and compositions for the treatment of eye disorders with increased intraocular pressureSYLENTIS SAU·Filed 2006·Granted Sep 22, 2009·36 cites·14 claims
- 0290US7902169B2Methods and compositions for the treatment of eye disorders with increased intraocular pressureSYLENTIS SAU·Filed 2009·Granted Mar 8, 2011·10 cites·32 claims
- 0388US8951982B2Methods and compositions for the treatment of eye disorders with increased intraocular pressureSYLENTIS SAU·Filed 2013·Granted Feb 10, 2015·7 cites·13 claims
- 0487US8030284B2Treatment of eye disorders characterized by an elevated intraocular pressure by siRNAsSYLENTIS SAU·Filed 2005·Granted Oct 4, 2011·7 cites·7 claims
- 0582US7807650B2Methods and compositions for the treatment of intestinal conditionsSYLENTIS SAU·Filed 2007·Granted Oct 5, 2010·5 cites·13 claims
- 0666US8354385B2Modulation of TRPV expression levelsSYLENTIS SAU·Filed 2006·Granted Jan 15, 2013·3 cites·17 claims
- 0754US10167473B2SiRNA and their use in methods and compositions for inhibiting the expression of the ORAI1 geneSYLENTIS SAU·Filed 2014·Granted Jan 1, 2019·0 cites·18 claims
- 0847US2019106700A1siRNA And Their Use In Methods And Compositions For Inhibiting The Expression Of The ORAI1 GeneSYLENTIS SAU·Filed 2018·Application pending·0 cites
- 0943US10017766B2SiRNA and their use in methods and compositions for inhibiting the expression of the FLAP geneSYLENTIS SAU·Filed 2014·Granted Jul 10, 2018·0 cites·15 claims
- 1043US9951338B2siRNA and their use in methods and compositions for inhibiting the expression of the PDK1 geneSYLENTIS SAU·Filed 2014·Granted Apr 24, 2018·0 cites·15 claims
- 1142US10752896B2siRNA and their use in methods and compositions for inhibiting the expression of the NRARP geneSYLENTIS SAU·Filed 2016·Granted Aug 25, 2020·0 cites·26 claims
- 1240US9808479B2SiRNA and their use in methods and compositions for the treatment and / or prevention of eye conditionsSYLENTIS SAU·Filed 2013·Granted Nov 7, 2017·0 cites·14 claims
- 1337US10011837B2SiRNAs and their use in methods and compositions for the treatment and/or prevention of eye conditionsSYLENTIS SAU·Filed 2015·Granted Jul 3, 2018·0 cites·11 claims
Join the waitlist — get patent alerts
Get an alert when SYLENTIS SAU files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →